Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Migraine

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    March 2025
  1. POLANCO FERNANDEZ M, Gangas Barranquero L, Gonzalez-Quintanilla V, Madera Fernandez J, et al
    [Successful Management of Wearing-off effect with Eptinezumab: Lessons from a case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies].
    Rev Neurol. 2025;80:38974.
    PubMed     Abstract available


    November 2024
  2. GARCIA-RON A, Arias-Vivas E, Bote-Gascon M, Gonzalez-Garcia N, et al
    [Usefulness of spontaneous drawing in the diagnostic guidance of pediatric patients with headache].
    Rev Neurol. 2024;79:265-271.
    PubMed     Abstract available


  3. KLAIC-LOPEZ DA, Paez-Granda D, Romero-Carvajal F
    [Hemiplegic migraine: classic findings in a rare pathology].
    Rev Neurol. 2024;79:263-264.
    PubMed    


    September 2024
  4. SANCHEZ-RODRIGUEZ N, Millan-Vazquez M, Fernandez-Panadero A, Gomez-Caminero AE, et al
    [Management of migraine by hospital emergency departments: a retrospective observational study carried out at the Hospital Universitario Virgen del Rocio].
    Rev Neurol. 2024;79:155-160.
    PubMed     Abstract available


    May 2024
  5. GARCIA-ESTEVEZ DA, Juanatey-Garcia A, Rodriguez-Garrido J, Sabbagh-Casado N, et al
    Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab.
    Rev Neurol. 2024;78:293-294.
    PubMed    


    January 2024
  6. MINGUEZ-OLAONDO A, Lopez-Bravo A, Quintas S, Nieves-Castellanos C, et al
    [New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants].
    Rev Neurol. 2024;78:47-57.
    PubMed     Abstract available


    October 2023
  7. VINUEZA-BUITRON P, Montes-Pena VJ, Rodriguez-Mena D, Boada-Cuellar JL, et al
    [Habituation deficit study in patients with episodic migraine thru nociceptive blink reflex].
    Rev Neurol. 2023;77:159-165.
    PubMed     Abstract available


    June 2023
  8. GUEVARA-MARTINEZ E, Arjona-Padillo A
    [Complete remission of a migraine after treatment with cisplatin].
    Rev Neurol. 2023;76:375.
    PubMed    


    May 2023
  9. PEREZ-RODRIGUEZ A, Bandres-Hernandez P, Anciones C, Terron-Cuadrado C, et al
    [Cardiovascular safety of new drugs for the acute and preventive treatment of migraine: gepants and ditans].
    Rev Neurol. 2023;76:295-308.
    PubMed     Abstract available


    April 2023
  10. MADERA J, Rodriguez-Rodriguez EM, Gonzalez-Quintanilla V, Perez-Pereda S, et al
    [Peripheral stimulation of the trigeminal nerve by nasopharyngeal swabbing as a possible trigger of migraine attacks].
    Rev Neurol. 2023;76:227-233.
    PubMed     Abstract available


    March 2023
  11. FRESAN-RESTITUTO D, Lacalle-Fabo E, Martin-Bujanda M, Sarobe-Carricas MT, et al
    Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one.
    Rev Neurol. 2023;76:213-216.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.